Exemptia 40mg Adalimumab Injection

Exemptia 40mg Adalimumab Injection is a prescription biologic medication used to treat a range of autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It contains Adalimumab, a monoclonal antibody that works by blocking tumor necrosis factor-alpha (TNF-α), a protein involved in triggering inflammation and immune system overactivity. By reducing inflammation, Exemptia 40mg Adalimumab Injection helps relieve symptoms, improve physical function, and support long-term disease control. Administered as a subcutaneous injection under the guidance of a healthcare professional, it is commonly used as part of a comprehensive treatment plan for chronic inflammatory disorders. Regular monitoring is recommended during therapy to assess treatment response and manage potential side effects. Patients should use Exemptia 40mg Injection only as prescribed by their healthcare provider.